# Pharmazz, Inc.

> Clinical-stage biopharmaceutical company in Willowbrook, Illinois, developing first-in-class
> therapeutics for critical care and neurovascular medicine. Pharmazz publishes no public API,
> SDK, developer portal or machine-readable specification of any kind.

Pharmazz, Inc. is a privately held Delaware corporation founded and led by pharmacologist
Dr. Anil Gulati. Its two lead small-molecule candidates are centhaquine (Lyfaquin), a
resuscitative agent for hypovolemic shock that holds marketing authorization from the Drugs
Controller General of India and is licensed to Dr. Reddy's Laboratories for the Indian market,
and sovateltide, an endothelin-B receptor agonist for cerebral ischemic stroke. Additional
pipeline programs target septic shock, acute kidney injury, cardiac arrest, acute spinal cord
injury, hypoxic-ischemic encephalopathy and Alzheimer's disease.

## API surface

Pharmazz is a drug-development company, not a software vendor. As of 2026-08-26 there is no
developer program, no public API, no OpenAPI/AsyncAPI/GraphQL contract, no MCP server, no A2A
agent card and no /.well-known/ document served on www.pharmazz.com. Every contract-discovery
probe returned HTTP 404. Do not attempt to call an API at this domain; none exists.

## Company

- [Home](https://www.pharmazz.com/): Corporate site.
- [About Us](https://www.pharmazz.com/about-us.php): Company overview and mission.
- [History](https://www.pharmazz.com/history.php): Company history.
- [Directors & Advisors](https://www.pharmazz.com/directors-advisors.php): Board and advisory board.
- [Management](https://www.pharmazz.com/management.php): Executive team.
- [Corporate Governance](https://www.pharmazz.com/corporate-governance.php): Governance policies.
- [Careers](https://www.pharmazz.com/career.php): Open positions.
- [Contact](https://www.pharmazz.com/contact-us.php): Corporate contact form.

## Product pipeline

- [Pipeline Overview](https://www.pharmazz.com/product-pipeline.php): All programs and phases.
- [Hypovolemic Shock](https://www.pharmazz.com/hypovolemic-shock.php): Centhaquine (Lyfaquin) lead indication.
- [Cerebral Ischemic Stroke](https://www.pharmazz.com/cerebral-ischemic-stroke.php): Sovateltide lead indication.
- [Septic Shock](https://www.pharmazz.com/septic-shock.php)
- [Acute Kidney Injury](https://www.pharmazz.com/acute-kidney-injury.php)
- [Cardiac Arrest](https://www.pharmazz.com/cardiac-arrest.php)
- [Acute Spinal Cord Injury](https://www.pharmazz.com/acute-spinal-cord-injury.php)
- [Hypoxic-Ischemic Encephalopathy](https://www.pharmazz.com/hypoxic-ischemic-encephalopathy.php)
- [Alzheimer's Disease](https://www.pharmazz.com/alzheimers-disease.php)
- [COVID-19 with ARDS](https://www.pharmazz.com/covid-19-with-ards.php)
- [Upcoming Products](https://www.pharmazz.com/upcoming-products.php)

## Investors and media

- [Investor Overview](https://www.pharmazz.com/overview.php)
- [Investors](https://www.pharmazz.com/investors.php)
- [Press Releases](https://www.pharmazz.com/press-releases.php)
- [Media Coverage](https://www.pharmazz.com/media-coverage.php)
- [Publications](https://www.pharmazz.com/publications.php): Peer-reviewed clinical literature.
- [Corporate Brochure (PDF)](https://www.pharmazz.com/assets/Pharmazz_Corporate_Brochure_01-2026.pdf)

## Optional

- [LinkedIn](https://www.linkedin.com/company/pharmazz)
- [Sitemap](https://www.pharmazz.com/sitemap.xml)

---
generated: 2026-08-26
method: generated
source: apis.yml + https://www.pharmazz.com/sitemap.xml (HTTP 200, fetched 2026-08-26)